Member Info for violindog

From markingtime on the other board :

"One factor re news update timing that nobody has mentioned is that Lindy has a tranche of (4.5p?) options expiring next month.She can't exercise them without cleansing herself of any inside information."

Burble....do drop him an email about Scancell : )

Five years after their diagnosis, 88% of those who took the pill were still alive, compared with 78% of the placebo group.

Not a huge margin against the placebo...but I guess anyone would go for a 10% improved chance of life.

So far it would appear Moditope will exceed 10% easily. 1 PR , 6SD , 6PD

-4.20%

The next AGM is roughly 6 months away …Scancell are hoping to fund further trials in clinic…” by doing deals “ … LD was very confident. So presumably negotiating was already taking place

Well let's hope so ...at this rate of sp decline a discounted dilutive fund raise would be very hard to stomach . There is certainly no active sp support from the BOD so we have to pray they are relying on data...

WTP....as long as it is not yet another NDA / "Collaboration agreement" with an unmamed party with unknown timelines.

Guess any networking helps....large bio pharma must be aware of the Moditope trial and of the results achieved so far . The derisory sp compared to true value ..as per Trinity ...and our valuation compared to US companies must surely entice someone to take a punt !

Potential of an intra day RNS if any deals are inked Stateside.

Crumbs, are LD and Cossery in the USA ...hope so !

....but the falling sp is deafening... -5.48%...14.5 to sell...and at this level after presenting at 2 USA conferences ! Patience indeed being tested .

Thanks Bermuda!

Probably being really stupid....sun stroke perhaps...but what is RCC ...?? Is it the renal cancer cohort ??

consented first patient this week to the RCC modi-1 and CPI cohort

Reading the posts this morning...all I need is for the results of Moditope, Scib etc to raise the share price to at least £1 by Jan end 2024 .

Scancell should have flown Trish over to ASCO.....to give a personal experience ; ))

Dwfender, Scancell are looking for , what was it... 240 ?

The change of presenter is a very late decision...must be a reason behind it ??? The only certainty... either Christian Ottenmeiner pulled out or Scancell wanted to take it "in house "

The poster, being presented by Dr Robert Miller, Medical Director.....

No Prof Christian Ottenmeiner then ...perhaps this forced the RNS ?

Indeed....and this is why if it could be proved that Moditope can slow down even progressive tumours, it is still a positive result as it could prolong life by X weeks, months or years ??

Botski, I would be really interested if those 6 patients that had progressive disease... although disappointing... may have had the progression slowed by Moditope. Can Scancell say ....without Moditope the tumor progression would be expected to be X size, but Moditope has slowed the progression to Y size . Even this would be extremely positive surely??

Crumbs, yes , it's logical that Scancell should try and present up to date data prior to the conference . These conferences are presenting so much data , much of it groundbreaking, ....unless there's something to shout about Moditope may get lost in the "white noise" . So come on Scancell, get some amazing results out !! Last RNS informed us 7 out of 13 had a good result, 1 PR (Trish) 6 SD and 6 unfortunately having PD. These results are excellent so let's hope some of the SD may have moved to PR and fingers crossed even some of the PD may have had a response.

On this, even the patients with PD....are these progressing as fast as they would have without receiving Moditope??? Even this would be a positive result but can it be measured ??

WTP, indeed, good to see some blue x